Hvivo Share Discussion Threads

[catchingmice] 13/1/2020 09:25

Nice move up this morning so every little bit helps when you are down

[qs99] 10/1/2020 14:55

interesting creeping up....

[discojames] 03/1/2020 10:26

I have to get this letter of acceptance off before 13th Jan, has anyone done theirs? I don't really understand who exactly to send it to, and some of the data I have to give.

[muchodinero] 31/12/2019 13:38

I wouldn't bank on it with that Muppet Trev in charge of the business. He's been a disaster at HVO!!!!!!!!!!

[loafofbread] 31/12/2019 09:09

Deal done.

Lets hope for a more successful 2020!

[sunningdale1] 16/12/2019 11:05

Following on from my previous Open Orphans (ORPH) post, Cathal Friel has delivered as promised with the all share merger with hVIVO (HVO). Seeing as HVO was trading at 30p at the start of the year, 2.47 ORPH shares for for each HVO share at 15.6p is great value. This follows partnerships with biopharma giant Ipsen Group and Venn’s deal with Carna Bioscience, and will leverage up and commercialise HVO’s sb through the Open Orphan health data platform.

At 5.6p this still values ORPH at just £14m - combine in HVO at £11m plus the preferred partnership agreements and ORPH is set for a big 2020

[muchodinero] 12/12/2019 18:24

So has anyone figured out what happens to any proceeds in the Imutex joint venture if you either reject or accept the offer from Open Orphan??

[muchodinero] 11/12/2019 17:19

So has anyone figured out why the proactive investor interview with the COO of Open Orphan was taken down???

[muchodinero] 10/12/2019 13:52

Flu v and Zika vaccines within Imutex are to be spun off and HVOs 49%% holding is to remain with existing HVO shareholders according to the investor presentation given by the COO of Orphan.

[muchodinero] 10/12/2019 13:51

Flu v and Zika vaccines within Imutex are to be spun off and HVOs 49%% holding is to remain with existing HVO shareholders according to the investor presentation given by the COO of Orphan.

[discojames] 10/12/2019 12:24

Yes I'm not convinced the Institutions will give this the go-ahead. The price is poor and far far below where they invested. Remember Flu-v alone has cost up to £100m to get to the stage its at and has been successful at every step so far, so why sell the company for £13m?

Sell off flu-v first then talk about a merger.

As you've pointed out, Trevor holds so few shares he just doesn't care and whilst he is supposed to have shareholder interests at heart, I think his only real interest is in finding a new job.

[loafofbread] 09/12/2019 20:10

Don't be so sure..

Trevor only holds 20k shares at the moment but low and behold, will be gifted 18.4m with this deal. Not to bad.

Although OO made a number of the larger players in HVIVO insiders, not one has given their support to this deal. In fact only 200k shares have, which is the BOD.

However, probably the best we could hope for, all things considered.

[muchodinero] 09/12/2019 19:28

So according to the interview with the COO of Open Orphan, the company is going to raise additional funding in th new year in the "merged company", at a significant premium to the new company's valuation to the benefit of existing shareholders, also existing HVO shareholders will be sole beneficiaries of the 49% stake in Seek Group if Flu-v / Zika vaccines get monitised in the spun out Seek Group assets. Looking much better than I first thought. Maybe Trevor and the BOD won't be shafting the shareholders???

[...]

[discojames] 09/12/2019 07:43

Haha suddenly your cross ramp becomes very relevant indeed!

[discojames] 02/12/2019 11:50

No one at all is interested in your cross ramping. 99% of people know what bad form that is.

[sunningdale1] 02/12/2019 08:41

For those interested in my previous post on ORPH. November delivered some more big news! Venn Life Sciences, which is part of the ORPH group has been selected as the preferred partner for pharma heavy weights Ipsen’s Data Management and Biostatistics. The preferred vendor structure will last for a 3-year period. Ipsen had sales in excess of €2.2 billion last year.

CEO Cathal Friel discusses in recent podcast hxxps://total-market-solutions.com/2019/11/13/open-orphan-news/

This partnership has already delivered substantial revenues for the Open Orphan group and positions the business as an integrated drug development partner for Biopharma companies in Europe such as Ipsen.

Venn have also signed a contract with Carna Bioscience for a First In Human Clinical pharmacology trial. The contract is expected to deliver significant revenue for the Company over the next 12months. Carna is a Japanese company developing innovative treatments against cancer and immune disorders.

[mister md] 01/11/2019 08:41

wheres that bernymadoff poster who was always ramping this cr@p ? Probably has multiple ids

[sunningdale1] 25/10/2019 16:03

Nothing happening IMO unfortunately. For those interested in alternative Pharma stocks (if you're not, no problem - this is a shameless plug) Open Orphan AIM:ORPH is one I’d recommend keeping an eye on - Share price has performed well over the last 6 months and it's no surprise - CEO Cathal Friel predicts 40% growth a year on podcast below with 2 million of his own money invested. hxxps://audioboom.com/posts/7361662-open-orphan-orph-ceo-cathal-friel-tells-alan-green-why-he-expects-40-percent-growth-year-on-year

Their health databank a standout for me and is progressing well. ORPH recently signed an agreement with Empiric Logic, a leading managed software service company. The Collaboration is the final stage in the completion of Open Orphan’s Genomic Health Data platform and will speed up its launch. The companies CCO Maurice Treacy is holding a live webinar on Wednesday 30th October 2019 at 19:00 (UK time) for those interested: hxxps://vtm.clickmeeting.com/orph

[newtothisgame3] 20/10/2019 15:40

#HVO Equity Income Fund was suspended in June. Companies such as #Tissue #Regenix, #Synairgen, #Arix ... via @ThisIsMoney

[mertymcs] 19/10/2019 09:55

Start of the decline.No sign of an update and cancelled contracts.

[therealapplegarth] 18/10/2019 21:56

THIS IS ONLY THE START YOU MUGS !

[mertymcs] 17/10/2019 14:01

Well this is looking like a dead fish now. Cannot even get in contact with anyone at the company to ask investor questions to.